157 related articles for article (PubMed ID: 32534699)
21. Low level of FOXL1 indicates a worse prognosis for gastric cancer patients.
Ertao Z; Jianhui C; Chuangqi C; Changjiang Q; Sile C; Yulong H; Shirong C; Hui W
Tumour Biol; 2016 Aug; 37(8):11331-7. PubMed ID: 26960689
[TBL] [Abstract][Full Text] [Related]
22. Expression and prognostic value of miR-486-5p in patients with gastric adenocarcinoma.
Chen H; Ren C; Han C; Wang D; Chen Y; Fu D
PLoS One; 2015; 10(3):e0119384. PubMed ID: 25793394
[TBL] [Abstract][Full Text] [Related]
23. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival.
He XX; Ding L; Lin Y; Shu M; Wen JM; Xue L
J Clin Pathol; 2015 May; 68(5):374-80. PubMed ID: 25731189
[TBL] [Abstract][Full Text] [Related]
24. KLF15 Inhibits Cell Proliferation in Gastric Cancer Cells via Up-Regulating CDKN1A/p21 and CDKN1C/p57 Expression.
Sun C; Ma P; Wang Y; Liu W; Chen Q; Pan Y; Zhao C; Qian Y; Liu J; Li W; Shu Y
Dig Dis Sci; 2017 Jun; 62(6):1518-1526. PubMed ID: 28421457
[TBL] [Abstract][Full Text] [Related]
25. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study.
Yu X; Hu F; Yao Q; Li C; Zhang H; Xue Y
BMC Cancer; 2016 Jul; 16():480. PubMed ID: 27418164
[TBL] [Abstract][Full Text] [Related]
26. Zinc finger protein 139 expression in gastric cancer and its clinical significance.
Li Y; Zhao Q; Fan LQ; Wang LL; Tan BB; Leng YL; Liu Y; Wang D
World J Gastroenterol; 2014 Dec; 20(48):18346-53. PubMed ID: 25561801
[TBL] [Abstract][Full Text] [Related]
27. CDK12 is a potential biomarker for diagnosis, prognosis and immunomodulation in pan-cancer.
Lu KQ; Li ZL; Zhang Q; Yin Q; Zhang YL; Ni WJ; Jiang LZ; He W; Wang B
Sci Rep; 2024 Mar; 14(1):6574. PubMed ID: 38503865
[TBL] [Abstract][Full Text] [Related]
28. Tensin4 promotes invasion and migration of gastric cancer cells via regulating AKT/GSK-3β/snail signaling pathway.
Qi X; Sun L; Wan J; Xu R; He S; Zhu X
Pathol Res Pract; 2020 Jul; 216(7):153001. PubMed ID: 32534709
[TBL] [Abstract][Full Text] [Related]
29. Clinical Outcomes in Cyclin-dependent Kinase 12 Mutant Advanced Prostate Cancer.
Reimers MA; Yip SM; Zhang L; Cieslik M; Dhawan M; Montgomery B; Wyatt AW; Chi KN; Small EJ; Chinnaiyan AM; Alva AS; Feng FY; Chou J
Eur Urol; 2020 Mar; 77(3):333-341. PubMed ID: 31640893
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Value of Cyclin D1 and CD44 Expression in Gastric Adenocarcinoma.
Ibrahim HM; AbdElbary AM; Mohamed SY; Elwan A; Abdelhamid MI; Ibrahim A
J Gastrointest Cancer; 2019 Sep; 50(3):370-379. PubMed ID: 29497929
[TBL] [Abstract][Full Text] [Related]
31. CDK12 regulates alternative last exon mRNA splicing and promotes breast cancer cell invasion.
Tien JF; Mazloomian A; Cheng SG; Hughes CS; Chow CCT; Canapi LT; Oloumi A; Trigo-Gonzalez G; Bashashati A; Xu J; Chang VC; Shah SP; Aparicio S; Morin GB
Nucleic Acids Res; 2017 Jun; 45(11):6698-6716. PubMed ID: 28334900
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive evaluation of FKBP10 expression and its prognostic potential in gastric cancer.
Liang L; Zhao K; Zhu JH; Chen G; Qin XG; Chen JQ
Oncol Rep; 2019 Aug; 42(2):615-628. PubMed ID: 31233188
[TBL] [Abstract][Full Text] [Related]
33. GRIK3: A novel oncogenic protein related to tumor TNM stage, lymph node metastasis, and poor prognosis of GC.
Gong B; Li Y; Cheng Z; Wang P; Luo L; Huang H; Duan S; Liu F
Tumour Biol; 2017 Jun; 39(6):1010428317704364. PubMed ID: 28631555
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer.
Peng XC; Zeng Z; Huang YN; Deng YC; Fu GH
Cancer Med; 2018 Jun; 7(6):2592-2600. PubMed ID: 29665316
[TBL] [Abstract][Full Text] [Related]
35. The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression.
Kanda M; Nomoto S; Oya H; Takami H; Shimizu D; Hibino S; Hashimoto R; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S214-21. PubMed ID: 25743330
[TBL] [Abstract][Full Text] [Related]
36. Increased expression of miR-181d is associated with poor prognosis and tumor progression of gastric cancer.
Li Z; Guo Q; Lu Y; Tian T
Cancer Biomark; 2019; 26(3):353-360. PubMed ID: 31524144
[TBL] [Abstract][Full Text] [Related]
37. SETD2 indicates favourable prognosis in gastric cancer and suppresses cancer cell proliferation, migration, and invasion.
Chen Z; Raghoonundun C; Chen W; Zhang Y; Tang W; Fan X; Shi X
Biochem Biophys Res Commun; 2018 Apr; 498(3):579-585. PubMed ID: 29522714
[TBL] [Abstract][Full Text] [Related]
38. Low expression of PDHA1 predicts poor prognosis in gastric cancer.
Song L; Liu D; Zhang X; Zhu X; Lu X; Huang J; Yang L; Wu Y
Pathol Res Pract; 2019 Mar; 215(3):478-482. PubMed ID: 30611622
[TBL] [Abstract][Full Text] [Related]
39. Protein expression profiles and clinicopathologic characteristics associate with gastric cancer survival.
Li W; Chen Y; Sun X; Yang J; Zhang DY; Wang D; Suo J
Biol Res; 2019 Aug; 52(1):42. PubMed ID: 31399040
[TBL] [Abstract][Full Text] [Related]
40. Keratin 17 expression correlates with tumor progression and poor prognosis in gastric adenocarcinoma.
Ide M; Kato T; Ogata K; Mochiki E; Kuwano H; Oyama T
Ann Surg Oncol; 2012 Oct; 19(11):3506-14. PubMed ID: 22695933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]